Story perspectives

Intuitive Surgical Beats Q3 2026 Earnings, Revenue Jumps 22%

By Drooid · Oct 21, 2026, 2:43 PM UTC · How we work

Summary

Story summary

Intuitive Surgical posted third-quarter 2026 earnings that beat adjusted expectations.
Revenue rose 22% to $3.05 billion, exceeding the $2.91 billion analyst estimate.
GAAP net income fell to $523 million because of a $450 million pre-tax settlement charge.
The company placed 546 da Vinci systems, including a record 315 da Vinci 5 units.
Pricing actions will reduce instrument revenue per procedure by 3%–5% beginning in 2027.

History

Historical Context

FDA’s 1999 clearance of Intuitive Surgical’s da Vinci system—overseen by the Center for Devices and Radiological Health—made it the first robotic platform for minimally invasive surgery, following a $1.2 billion investment and a partnership with Cleveland Clinic that performed the first operation in 2000. The approval foreshadowed later FDA reforms, such as the 2007 amendments that added priority-review vouchers.

1 of 2

Story summary

Intuitive Surgical posted third-quarter 2026 earnings that beat adjusted expectations.
Revenue rose 22% to $3.05 billion, exceeding the $2.91 billion analyst estimate.
GAAP net income fell to $523 million because of a $450 million pre-tax settlement charge.
The company placed 546 da Vinci systems, including a record 315 da Vinci 5 units.
Pricing actions will reduce instrument revenue per procedure by 3%–5% beginning in 2027.

1 / 2